Search research articles
Contact Us
Filters
Showing results (551-560 of 777) with videos related to
Page
of 78
Sort By:
Hepatology Communications
|
September 14, 2023
Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy
Bernhard Scheiner, Katharina Lampichler, Katharina Pomej, et al.
Hepatology International
|
August 21, 2023
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
Benedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Plos One
|
October 28, 2014
Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains
Vikash Pandey, Marc Sultan, Karl Kashofer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 13, 2026
Reliability of Hepatic Steatosis Quantification by Controlled Attenuation Parameter in Steatotic Liver Disease
Lucie Simonis, Yannick Marcour, Jan Embacher, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 27, 2023
Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
Paul Fellinger, Hannes Beiglböck, Georg Semmler, et al.
Alimentary Pharmacology & Therapeutics
|
September 21, 2024
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortality
Lukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Journal of Hepatology
|
February 1, 2020
FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis
Katrin Panzitt, Emilian Jungwirth, Elisabeth Krones, et al.
Alimentary Pharmacology & Therapeutics
|
November 4, 2024
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' Reply
Lukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
JHEP Reports : Innovation in Hepatology
|
October 11, 2023
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ
Christoph Grander, Moritz Meyer, Daniel Steinacher, et al.
JHEP Reports : Innovation in Hepatology
|
March 24, 2025
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis
Andrea Kornfehl, Anja Tiede, Paul Hemetsberger, et al.
Page
of 78
Search research articles
Search
Showing results (551-560 of 777) with videos related to
Sort By:
Page
of 78
Hepatology Communications
|
September 14, 2023
Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy
Bernhard Scheiner, Katharina Lampichler, Katharina Pomej, et al.
Hepatology International
|
August 21, 2023
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
Benedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Plos One
|
October 28, 2014
Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains
Vikash Pandey, Marc Sultan, Karl Kashofer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 13, 2026
Reliability of Hepatic Steatosis Quantification by Controlled Attenuation Parameter in Steatotic Liver Disease
Lucie Simonis, Yannick Marcour, Jan Embacher, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 27, 2023
Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
Paul Fellinger, Hannes Beiglböck, Georg Semmler, et al.
Alimentary Pharmacology & Therapeutics
|
September 21, 2024
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortality
Lukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Journal of Hepatology
|
February 1, 2020
FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis
Katrin Panzitt, Emilian Jungwirth, Elisabeth Krones, et al.
Alimentary Pharmacology & Therapeutics
|
November 4, 2024
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' Reply
Lukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
JHEP Reports : Innovation in Hepatology
|
October 11, 2023
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ
Christoph Grander, Moritz Meyer, Daniel Steinacher, et al.
JHEP Reports : Innovation in Hepatology
|
March 24, 2025
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis
Andrea Kornfehl, Anja Tiede, Paul Hemetsberger, et al.
Page
of 78